Loading chat...

CT SB00083

Bill

Official Source

Status

Introduced

2/14/2018

Primary Sponsor

Mae Flexer

Click for details

Origin

Senate

2018 General Assembly

AI Summary

  • Imposes a surcharge on all pharmaceutical companies that sell products in the state
  • Increases funding for opioid addiction treatment facilities using revenue from the surcharge
  • Referred to the Committee on Public Health
  • Introduced by Senator Flexer, 29th District, during the February 2018 legislative session
  • Aims to combat the opioid epidemic

Legislative Description

An Act Increasing Funding For Opioid Addiction Treatment Facilities.

Last Action

Referred to Joint Committee on Public Health

2/14/2018

Committee Referrals

Public Health2/14/2018

Full Bill Text

No bill text available